Classifying the Oncogenicity of 100 Variants from Pediatric Cancer Patients Using a Standardized Assessment Framework

This 13-minute conference talk from the Cancer Genomics Consortium (CGC) 2024 Annual Meeting features Wesley Goar presenting research on classifying the oncogenicity of 100 variants identified in pediatric cancer patients using a standardized assessment framework. Learn about the methodologies and findings that contribute to accurate genomic diagnoses for cancer patients. The CGC represents clinical cytogeneticists, molecular geneticists, and molecular pathologists dedicated to education and promoting best practices in clinical cancer genomics, with the vision that all cancer patients receive accurate genomic diagnoses to guide appropriate therapy. The organization aims to be the authoritative source for guidance on clinical cancer genomic testing best practices.